Previously treated cases tested for RR-/MDR-TB in Eastern Mediterranean (WHO region)

Eastern Mediterranean (WHO region): Previously treated cases tested for RR-/MDR-TB was 74.0% in 2024. ◆ Volatile

Latest (2024)
74.0%
Change on year
down 5.1%
Rank
10th
of 11 groups
All-time high
95.0%
in 2022
All-time low
0.8%
in 2005
Years of data
20
2005–2024

Previously treated cases tested for RR-/MDR-TB in Eastern Mediterranean (WHO region), 2005–2024

0204060801002005201420242005: 0.792006: 3.12007: 6.72008: 9.52009: 7.12010: 6.32011: 72012: 112013: 212014: 522015: 662016: 552017: 532018: 832019: 862020: 672021: 842022: 952023: 782024: 74

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for previously treated cases tested for rr-/mdr-tb in Eastern Mediterranean (WHO region) is 74.0%, measured in 2024.

That represents a change of down 5.1% on the previous year and up 42.3% over ten years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in Eastern Mediterranean (WHO region) peaked at 95.0% in 2022 and was at its lowest, 0.8%, in 2005.

The series is highly variable year to year, so single readings are best treated with caution.

Previously treated cases tested for RR-/MDR-TB in Eastern Mediterranean (WHO region), year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in Eastern Mediterranean (WHO region), 2005 to 2024.
Year Value Change
2005 0.8%
2006 3.1% +292.4%
2007 6.7% +116.1%
2008 9.5% +41.8%
2009 7.1% -25.3%
2010 6.3% -11.3%
2011 7.0% +11.1%
2012 11.0% +57.1%
2013 21.0% +90.9%
2014 52.0% +147.6%
2015 66.0% +26.9%
2016 55.0% -16.7%
2017 53.0% -3.6%
2018 83.0% +56.6%
2019 86.0% +3.6%
2020 67.0% -22.1%
2021 84.0% +25.4%
2022 95.0% +13.1%
2023 78.0% -17.9%
2024 74.0% -5.1%

Averages by decade

DecadeAverage LowestHighest Years
2000s 5.4% 0.8% 9.5% 5
2010s 44.0% 6.3% 86.0% 10
2020s 79.6% 67.0% 95.0% 5

More health data for Eastern Mediterranean (WHO region)

All data for Eastern Mediterranean (WHO region) →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in Eastern Mediterranean (WHO region)?
Previously treated cases tested for rr-/mdr-tb in Eastern Mediterranean (WHO region) was 74.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in Eastern Mediterranean (WHO region)?
The highest recorded value was 95.0% in 2022.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Eastern Mediterranean (WHO region)?
The lowest recorded value was 0.8% in 2005.
How does Eastern Mediterranean (WHO region) rank for previously treated cases tested for rr-/mdr-tb?
Eastern Mediterranean (WHO region) ranks 10th out of 11 groups with data for 2024.
Is previously treated cases tested for rr-/mdr-tb rising or falling in Eastern Mediterranean (WHO region)?
Over the last ten years it is up 42.3%. The long-run trend across the full record is volatile.
Where does this Eastern Mediterranean (WHO region) data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in Eastern Mediterranean (WHO region). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 06 September 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/eastern-mediterranean-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/eastern-mediterranean-who-region/">Previously treated cases tested for RR-/MDR-TB in Eastern Mediterranean (WHO region)</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed